Thymic carcinoma staging: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}}{{PSD}} | {{CMG}}; {{AE}}{{PSD}} | ||
==Overview== | ==Overview== | ||
The staging of thymic carcinoma is based on the Masoka and GETT staging system. | |||
==Masaoka TNM Staging (1999)== | ==Masaoka TNM Staging (1999)== | ||
{| | {| |
Revision as of 15:24, 4 January 2016
Thymic Carcinoma Microchapters |
Diagnosis |
---|
Case Studies |
Thymic carcinoma staging On the Web |
American Roentgen Ray Society Images of Thymic carcinoma staging |
Risk calculators and risk factors for Thymic carcinoma staging |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
The staging of thymic carcinoma is based on the Masoka and GETT staging system.
Masaoka TNM Staging (1999)
Original Masaoka Staging (1991)
- Stage I - Macroscopically and microscopically completely encapsulated
- Stage II - Macroscopic invasion into surrounding fatty tissues or mediastinal pleura or microscopic invasion into the capsule
- Stage III - Macroscopic invasion into adjacent organs or intrathoracic metastases
- Stage IVA - Pleural or pericardial implants/dissemination
- Stage IVB - Nodal or hematogenous metastases
GETT Staging
- Stage IA - Encapsulated, completely resected
- Stage IB - Macroscopically completely resected but suspicion of mediastinal adhesions or potential capsular invasion at surgery
- Stage II - Invasive tumor, completely resected
- Stage IIIA - Invasive tumor, subtotal resection
- Stage IIIB - Invasive tumor, biopsy alone
- Stage IVa - Supraclav or pleural met
- Stage IVb - Distant metastases[1]